Talk to our Consultant - UAE Heart Failure Treatment Devices Market Size & Trends by 2030

UAE Heart Failure Treatment Devices Market Research Report: Forecast (2025-2030)

UAE Heart Failure Treatment Devices Market Report - By Product Type (Implantable Cardioverter, Cardiac Resynchronization Therapy (CRT), [Cardiac Resynchronization Therapy Pacemaker (CRT- P), Cardiac R... ... (CRT- P), Cardiac Resynchronization Therapy Defibrillator (CRT- D)], Others (Impella, LVAD, etc.)), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) and Others Read more

Healthcare
Dec 2024
Pages 138
Report Format: PDF, Excel, PPT

Market Definition

Heart Failure Treatment Devices including implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy (CRT), and others are medical devices for treating and managing patients with advanced heart failure. These devices have been significantly improving the lives of patients as well as reducing death rates from heart failure & sudden cardiac arrest.

Market Insights & Analysis: The UAE Heart Failure Treatment Devices Market (2025-30):

The UAE Heart Failure Treatment Devices Market size was valued at around USD 221.85 million in 2024 and is projected to reach USD 442.97 million by 2030. The market is also estimated to grow at a CAGR of around 12% during the forecast period, i.e., 2025-30.

In the country, obesity levels have been soaring consistently. This is primarily driven by changes in cultural & social environments, unhealthy and improper diet and nutrition, lack of involvement in physical activities, the issue of binge eating disorder, especially among youths, etc. Obesity has been one of the leading causes behind elevating the risk for cardiovascular diseases (CVDs) as per the 2024 Fact by the World Health Organization (WHO). In the UAE as well, this has been contributing to the increased number of cases of CVDs like heart failure. Therefore, the market for heart failure treatment devices has expanded in the UAE, with positive growth trends. For instance, obesity prevalence as the UAE government mentioned in 2023 was around 27.8% of the total population. Also, 7.5 million people including adults, children, and adolescents as stated by the World Obesity Federation, 2035, will be living with overweight and obesity in the UAE.

Report Coverage	Details
Historical Years	2020-23
Base Years	2024
Forecast Years	2025-30
Market Value in 2024	USD 221.85 Million
Market Value By 2030	USD 442.97 Million
CAGR (2025-30)	12%
Top Key Players	Medtronic, Abbott, Boston Scientific Corporation, Biotronik, Johnson & Johnson Services, Inc. (Abiomed), and others
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation, Recent Strategic Moves by Companies, Primary Stakeholders, Analysis of Import and Export Trends, Competitive Landscape Assessment, Emerging Opportunities, Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Also, in many emirates, patients with hypertension have been increasing at concerning rates. This has been due to stress, obesity, & elevating diabetes rates in the country. The CDC fact even mentions that health conditions like diabetes & obesity tend to increase the possibility of high blood pressure. Hence, as the rates of these conditions like obesity & diabetes have been surging in the country subsequent rise has been there in the cases of hypertension. For instance, in the UAE, around 990,900 adults aged between 20 and 79 years were affected by diabetes, and the cases are expected to increase to about 1,177,500 by 2030. Likewise, heart failure cases because of hypertension and diabetes which tend to increase the risk of developing heart failure by >2x as pointed out by the American Heart Association have been reported in the country, subsequently raising the demand for devices like ICD & CRT.

Moreover, heart transplantation rates have been low in the country because of a shortage of donors. This has led healthcare providers in the nation to highly depend upon devices like impella & LVAD which are crucial for patients to the point they receive heart transplants.

Additionally, in the UAE, there has been a strong presence of major key players like Medtronic & Abbott that through their distributors have been ensuring the availability of advanced heart failure treatment technologies like ICD, CRT, etc. to the healthcare facilities in the UAE without compromising the patient's condition.

Market Segmentation
Introduction
1. Market Definition
2. Research Process
3. Assumptions
Executive Summary
The UAE Heart Failure Treatment Devices Market Trends & Developments
The UAE Heart Failure Treatment Devices Market Dynamics
1. Drivers
2. Challenges
The UAE Heart Failure Treatment Devices Market Regulations, Policies & Standards
The UAE Heart Failure Treatment Devices List of Distributors
The UAE Heart Failure Treatment Devices Supply Chain Analysis
The UAE Heart Failure Treatment Devices Market Hotspot & Opportunities
The UAE Heart Failure Treatment Devices Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Size & Analysis
  1. By Product Type
    1. Implantable Cardioverter-Defibrillator (ICD)-Market Size & Forecast 2020-2030, USD Million
    2. Cardiac Resynchronization Therapy (CRT)- Market Size & Forecast 2020-2030, USD Million
      1. Cardiac Resynchronization Therapy Pacemaker (CRT- P)- Market Size & Forecast 2020-2030, USD Million
      2. Cardiac Resynchronization Therapy Defibrillator (CRT- D)- Market Size & Forecast 2020-2030, USD Million
    3. Others (Impella, LVAD, etc.)- Market Size & Forecast 2020-2030, USD Million
  2. By End User
    1. Hospitals-Market Size & Forecast 2020-2030, USD Million
    2. Specialty Clinics-Market Size & Forecast 2020-2030, USD Million
    3. Ambulatory Surgical Centers-Market Size & Forecast 2020-2030, USD Million
  3. By Region
    1. Dubai
    2. Abu Dhabi & Ain
    3. Sharjah & North Emirates
    4. Rest of the UAE
  4. By Company
    1. Competition Characteristics
    2. Revenue Shares
The UAE Heart Failure Treatment Devices Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Company Profile
  1. Medtronic
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Abbott
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Biotronik
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Boston Scientific Corporation
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Johnson & Johnson Services, Inc. (Abiomed)
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying